EyeCool Therapeutics, Inc.


Developer of therapies and medical-device approaches focused on Chronic Ocular Surface Pain (COSP). The organization assembles clinical, engineering and regulatory expertise to advance translational ophthalmic programs, clinical development, and product engineering for device- and drug-based solutions addressing persistent ocular pain.

Industries

N/A

Nr. of Employees

small (1-50)

EyeCool Therapeutics, Inc.


Patents

Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry

US-11653969-B2

View Details

Methods of alleviating symptoms of ocular surface discomfort using medical ice slurry

US-11399882-B2

View Details

Services

Planning and execution support for clinical programs focused on Chronic Ocular Surface Pain, including protocol and strategy.

Engineering design, prototyping and product development services across device classes and HCT/P products.

Implementation of quality management systems, design control, risk management programs, audits and compliance training.

Preclinical research using material science and additive manufacturing methods to inform device and drug development.

Expertise Areas

  • Clinical trial management
  • Medical device development
  • Regulatory compliance and QMS
  • Ophthalmic and ocular pain clinical expertise
  • Show More (4)

Key Technologies

  • Medical device design and development
  • Additive manufacturing (3D printing)
  • Material science for medical devices
  • Clinical trial design
  • Show More (4)

News & Updates

Reference article describing Chronic Ocular Surface Pain (COSP) as a distinct disease state and highlighting unmet therapeutic needs.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.